Latest Corporate News

UPDATED: PHARMASCIENCE INC. LAUNCHES PMS-FLUTICASONE HFA 50 and 125 mcg FOR THE TREATMENT OF STEROID-RESPONSIVE BRONCHIAL ASTHMA IN ADULTS AND CHILDREN

Read more

Pharmascience Canada is proud to launch generic drug pms-EVEROLIMUS 2.5 mg, 5 mg and 10 mg

Read more

Pharmascience International Market Entry in Mexico!

Read more

Pharmascience Canada Launches pms-DIMETHYL FUMARATE for the Treatment of Relapsing Remitting Multiple Sclerosis!

Read more

Brochure

MORE THAN 30 YEARS OF GROWTH AND STRENGTH

Our Commitment

LEARN MORE ABOUT OUR QUALITY PRODUCTS AND SUPPLY